ENGOT (European Network of Gynaecological Oncology Trial Groups), today announced that the Phase 3 ENGOT-OV16/NOVA trial of niraparib successfully achieved ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE